Jesse Goodman's most recent trade in Intellia Therapeutics Inc was a trade of 13,300 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 13,300 | 13,300 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 9,200 | 33,559 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Sale of securities on an exchange or to another person at price $ 9.23 per share. | 30 Jun 2025 | 1,547 | 24,359 (0%) | 0% | 9.2 | 14,279 | Common Stock |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Sale of securities on an exchange or to another person at price $ 9.56 per share. | 30 Jun 2025 | 1,547 | 25,906 (0%) | 0% | 9.6 | 14,789 | Common Stock |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,450 | 11,450 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 8,000 | 27,453 (0%) | 0% | 0 | Common Stock | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 17.07 per share. | 11 Apr 2025 | 44 | 38,812 (0%) | 0% | 17.1 | 751 | Ords 0.31p |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 38.81 per share. | 25 Mar 2025 | 6,842 | 38,768 (0%) | 0% | 38.8 | 265,504 | Ords 0.31p |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 19.64 per share. | 20 Mar 2025 | 498 | 31,926 (0%) | 0% | 19.6 | 9,779 | Ords 0.31p |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | Sale or transfer of securities back to the company at price $ 16.67 per share. | 10 Jan 2025 | 36 | 30,224 (0%) | 0% | 16.7 | 600 | Ords 0.31p |
| GSK PLC (ADR) | Goodman Jesse | Non-Executive Director | 20 Dec 2024 | 542 | 30,188 (0%) | 0% | 16.9 | 9,162 | Ords 0.31p | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 11 Oct 2024 | 28 | 29,646 (0%) | 0% | 19.5 | 547 | Ords 0.31p | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 23 Sep 2024 | 448 | 29,618 (0%) | 0% | 20.5 | 9,187 | Ords 0.31p | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 12 Jul 2024 | 24 | 29,170 (0%) | 0% | 19.7 | 472 | Ords 0.31p | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 20 Jun 2024 | 450 | 29,146 (0%) | 0% | 20.4 | 9,172 | Ords 0.31p | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,515 | 11,515 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 7,737 | 19,453 (0%) | 0% | 0 | Common Stock | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 12 Apr 2024 | 18 | 28,696 (0%) | 0% | 20.5 | 369 | Ords 0.31p | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 20 Mar 2024 | 438 | 28,678 (0%) | 0% | 21.0 | 9,177 | Ords 0.31p | |
| GSK PLC (ADR) | Jesse Goodman | Non-Executive Director | 12 Jan 2024 | 12 | 27,108 (0%) | 0% | 20.1 | 241 | Ords 0.31p | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 11,716 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 7,291 (0%) | 0% | 0 | Common Stock |